Viewing Study NCT03822195


Ignite Creation Date: 2025-12-24 @ 1:39 PM
Ignite Modification Date: 2025-12-30 @ 7:28 AM
Study NCT ID: NCT03822195
Status: WITHDRAWN
Last Update Posted: 2020-07-24
First Post: 2019-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lectine Pathway in Unstable Carotid Plaque
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:

Study Overview

Official Title: Evaluation of Lectine Pathway in Assessment of Unstable Carotid Plaque
Status: WITHDRAWN
Status Verified Date: 2020-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: PI changed Institution
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study is aimed to investigate the possible role of lectin pathway - an alternative pathway of complement activation - in affecting stability of carotid atherosclerotic plaques and the possible correlations with clinical neurologic features.
Detailed Description: In addition to the known hemodynamic criteria, instable carotid plaques can be responsible for brain ischemia, therefore is paramount to identify preoperatively possible markers of plaque instability. The study is aimed to investigate the possible role of lectin pathway - an alternative pathway of complement activation - in affecting stability of carotid atherosclerotic plaques and the possible correlations with clinical neurologic features. Study population will include 40 patients with internal carotid artery stenosis \>=70% (assessed by echocolordoppler), symptomatic or asymptomatic, surgically treated by endoarterectomy. Removed plaques will be evaluated by histologic exam and immunofluorescence for ficolins 1-2-3 and Mannose Binding Lectin (MBL). Plasma samples will be used for ELISA test of lectin pathway complement activation.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: